ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,011.12
      -0.22%
      US Tech 100
      16,805.20
      -0.77%
      Dow Jones
      37,775.38
      0.06%
      Brent Oil
      86.795
      0.44%
      Bitcoin
      64,470.12
      1.51%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lyell Immunopharma Inc (LYEL)

      7. Lyell Immunopharma Inc (LYEL) News

      LYEL

      Lyell Immunopharma (LYEL)

      Lyell Immunopharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LYEL
      DateTimeSourceHeadlineSymbolCompany
      03/05/20244:30PMGlobeNewswire Inc.Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual MeetingNASDAQ:LYELLyell Immunopharma Inc
      02/28/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
      02/28/20244:05PMGlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023NASDAQ:LYELLyell Immunopharma Inc
      02/26/20244:05PMGlobeNewswire Inc.Lyell Immunopharma Announces Participation in March Investor ConferencesNASDAQ:LYELLyell Immunopharma Inc
      02/13/20248:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
      02/13/20248:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
      02/13/20248:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
      01/03/20244:05PMGlobeNewswire Inc.Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LYELLyell Immunopharma Inc
      11/20/20238:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
      11/20/20238:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
      11/20/20238:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
      11/20/20234:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
      11/09/20234:05PMGlobeNewswire Inc.Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of MelanomaNASDAQ:LYELLyell Immunopharma Inc
      11/07/20234:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYELLyell Immunopharma Inc
      11/07/20234:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
      11/07/20234:05PMGlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023NASDAQ:LYELLyell Immunopharma Inc
      10/31/20239:00AMGlobeNewswire Inc.Lyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL ManufacturingNASDAQ:LYELLyell Immunopharma Inc
      09/27/20239:00AMGlobeNewswire Inc.Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:LYELLyell Immunopharma Inc
      09/11/20239:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
      09/11/20238:00AMPR Newswire (US)Cellares and Lyell to Evaluate Automated Manufacturing of Lyell's CAR T-Cell Therapy on Cellares' Cell Shuttle PlatformNASDAQ:LYELLyell Immunopharma Inc
      09/11/20238:00AMGlobeNewswire Inc.Cellares and Lyell to Evaluate Automated Manufacturing of Lyell’s CAR T-Cell Therapy on Cellares’ Cell Shuttle PlatformNASDAQ:LYELLyell Immunopharma Inc
      08/31/20234:05PMGlobeNewswire Inc.Lyell Immunopharma to Participate in Upcoming Investor ConferencesNASDAQ:LYELLyell Immunopharma Inc
      08/08/20234:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYELLyell Immunopharma Inc
      08/08/20234:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
      08/08/20234:05PMGlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023NASDAQ:LYELLyell Immunopharma Inc
      07/05/20234:05PMGlobeNewswire Inc.Lyell Immunopharma Appoints Matthew Lang as Chief Business OfficerNASDAQ:LYELLyell Immunopharma Inc
      06/21/20234:55PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LYELLyell Immunopharma Inc
      06/20/20234:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LYELLyell Immunopharma Inc
      06/20/20234:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LYELLyell Immunopharma Inc
      06/20/20234:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LYELLyell Immunopharma Inc
       Showing the most relevant articles for your search:NASDAQ:LYEL